These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21087629)

  • 1. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH; Lager M; Henningsson AJ; Tjernberg I
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
    Bennet R; Lindgren V; Zweygberg Wirgart B
    Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.
    van Burgel ND; Brandenburg A; Gerritsen HJ; Kroes AC; van Dam AP
    Clin Microbiol Infect; 2011 Oct; 17(10):1495-500. PubMed ID: 21375653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C6-peptide serology as diagnostic tool in neuroborreliosis.
    Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
    APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005].
    Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA
    Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
    Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
    Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
    Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms.
    Tveitnes D; Øymar K; Natås O
    Scand J Infect Dis; 2009; 41(5):355-62. PubMed ID: 19253089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
    Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL13 chemokine in pediatric and adult neuroborreliosis.
    Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
    Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?].
    Rupprecht T
    MMW Fortschr Med; 2009 Apr; 151(18):8. PubMed ID: 19769063
    [No Abstract]   [Full Text] [Related]  

  • 16. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland A
    J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
    Vermeersch P; Resseler S; Nackers E; Lagrou K
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
    Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
    J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.
    Øymar K; Tveitnes D
    Scand J Infect Dis; 2009; 41(2):88-94. PubMed ID: 19065451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.
    Pöyhönen H; Lähdesmäki T; Hytönen J; Peltola V
    Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.